Editorial from Graham Beastall, IFCC President

Report from the IFCC Council Meeting

Introduction:
The Council is the overall governing body of IFCC. It meets once
every three years, usually in association with the IFCC WorldLab
congress. Accordingly, the 2011 IFCC Council meeting was held on
Sunday 15 May in Berlin. Approximately 100 people, including 57
representatives from IFCC Full Member National Societies who were
empowered to vote, attended the Council meeting.
Presentations:
The first part of the Council meeting was chaired by Paivi
Laitinen (Honorary Secretary) and comprised reports from:
| Graham Beastall |
President |
| Chris Lam |
Vice President |
| Ghassan Shannan |
Treasurer |
| Joseph Passarelli |
Corporate Member representative |
| Ian Young |
Chair of Scientific Division |
| Janet Smith |
Chair of Education & Management Division |
| Ellis Jacobs |
Chair of Communications and Publications Division |
Copies of all these reports are available from the Executive
Board section of the IFCC website www.ifcc.org
Election of Executive Board for 2012-2014:
Professor Jocelyn Hicks (Past President) conducted the election
of the next Executive Board. The following individuals were elected
to serve from 1 January 2012 until 31 December 2014:
| President |
Graham Beastall |
UK |
| Vice President |
Howard Morris |
AU |
| Secretary |
Sergio Bernardini |
IT |
| Treasurer |
Bernard Gouget |
FR |
| Member |
Ulisses Tuma |
BR |
| Member |
Vanessa Steenkamp |
ZA |
| Member |
Larry Kricka |
US |
In addition Jocelyn Hicks (US) will continue as Past President
for the duration of the next Executive Board. A photo montage of
the new Executive Board is shown. The new Executive Board includes
four new faces. Short biographies of each of these newly appointed
individuals are included.

Newly Elected Vice President of IFCC Professor Howard Morris,
Australia

Professor Howard Morris is Professor of Medical Science at
the University of South Australia and a Chief Medical Scientist in
Chemical Pathology at SA Pathology, Adelaide Australia. He leads a
research group investigating the pathophysiology of metabolic bone
disease and the effects of hormones including vitamin D funded by
the National Health and Medical Research Council and Australian
Research Council, the major competitive funding bodies in
Australia. His latest work has identified the basis for vitamin D
requirement to reduce the risk of fractures amongst the elderly. He
was invited to present the Louis Avioli Memorial Lecture at the
2009 Annual Scientific Meeting of the American Society for Bone and
Mineral Research on this topic. He is also Deputy Chair of a South
Australian Department of Health Working Party on Osteoporosis and
Fracture Prevention. He had 18 years experience working in
diagnostic clinical biochemistry in the field of immunoassay and
endocrinology and continues an active professional life in
laboratory medicine. Between 2002 and 2008 he was the Secretary of
the Scientific Division of the International Federation of Clinical
Chemistry and Laboratory Medicine (IFCC) and a member of the IFCC
Task Force on the Global Campaign on Diabetes Mellitus. He
currently is a member of the IFCC Task Force on International
Clinical Liaison. Between 2003 and 2009 he was the Director of the
Hanson Institute in Adelaide, South Australia.
Newly Elected Secretary of IFCC Professor Sergio Bernardini,
Italy

Professor Sergio Bernardini MD, PhD, currently is a full
professor of Clinical Biochemistry and Clinical Molecular Biology
at the Department of Internal Medicine of The University of Rome
Tor Vergata, and the head physician of the Clinical Molecular
Biology Unit at the Tor Vergata University Hospital.
He received his degree in Medicine in 1986 and the PhD in
Paediatric Sciences in 1995. He has specialized in Paediatrics
(1990) and in Clinical Chemistry and Biochemistry (1998).
He act as the president of the undergraduate course in
"Diagnostic laboratory techniques in the medical field" and, as a
clinical laboratory research consultant with Bambino Gesu'
Children's Hospital in Rome.
He is a member of the Italian Society of Clinical Biochemistry
(SiBioC), where he form part of the committee of Clinical Molecular
Biology, as well as the Italian Society of Biochemistry (SIB)
and the Italian Society of Allergology and Immunology (SIAIC). His
international activities include membership of theEditorial
Advisory Board of The Encyclopedia of Life Sciences.
As a professor he has several teaching responsibilities including
a Bachelor's course in diagnostic laboratory techniques in the
medical field, degree courses in medicine, medical biotechnologies,
movement sciences and postgraduate courses in Clinical
Biochemistry, Gastroenterology, Neurology, Medical Genetics,
Allergology and Immunology, and Paediatrics.
The research interests are diverse in nature and have included
work in paediatric endocrinology with particular interest in growth
hormone and insulin like growth factors and their binding proteins.
He has also worked on apoptotic pathways in oncology, in particular
neuroblastoma, as well as on glutathione transferases, a family of
enzymes involved in cell detoxification and in the control of the
programmed cell death. He has collaborated in the application of
molecular biology and proteomic methods and techniques in research
applied to neurodegenerative diseases, oncology and
pharmacogenetics. Since 2009 he has collaborated in the application
of molecular biology and biochemical methods to monitoring of sport
training and performance.
Sergio is married to Elisabetta since 1998 and has a son, Andrew
21 years old, and a daughter Marta aged 19. His personal interests
include football, theatre and travelling.
Newly Elected Member of IFCC Executive Board Prof Vanessa
Steenkamp, South Africa

Vanessa obtained her MSccum laudein Biochemistry at the
University of Pretoria while employed as a Junior Lecturer.
She took up at position at the South African Institute for Medical
Research, now the National Health Laboratory Services in the
Department of Endocrinology. She was appointed Lecturer in the
Department of Chemical Pathology, University of the Witwatersrand
and obtained her PhD in Clinical Toxicology. She returned to
the University of Pretoria as Senior Lecturer in the Department of
Urology and was transferred to the Department of Pharmacology as
head of the Phytopharmacology Unit. Vanessa's research
interest focuses on traditional herbal remedies and their effect on
patients, as well as the development of methods for the detection
of these active compounds in biological fluids. She is also
involved in pre-clinical testing of traditional herbal remedies
which includes the isolation of active compounds and development of
new drugs. Vanessa is the author and co-author of >60
scientific papers. She has received a number of awards for
her research both nationally and internationally, amongst which is
the prestigious Friedel Sellschop award, formerly known as the
University of the Witwatersrand Young Researcher in 2001 and
Exceptional Young Researcher of the University of Pretoria in 2006,
two of the leading academic institutions in the country. In
2007 she received two international awards in her recognition to
research as a young scientist; from the International Association
of Therapeutic Drug Monitoring and Clinical Toxicology and the
American Association of Clinical Chemistry. Currently she is
supervising 15 postgraduate students.
She is the President of the African Federation of Clinical
Chemistry, Vice-President of the Toxicology Society of South
Africa, Secretary-General of the South African Association of Basic
and Clinical Pharmacology, Treasurer of the Federation of the South
African Society of Pathologists and Past President of the South
African Association of Clinical Biochemistry. She serves as
reviewer for 18 international peer-reviewed journals and is on the
editorial board of 4 journals. She has 149 conference
contributions and has been the invited speaker on 16
occasions.
Vanessa is the mother of four boys; triplets Brendon, Dylan, Lance
(10) and Jacques, 14. Both herself and husband, Johan are
very involved with coaching of children in school sports. She
is the manager of a provincial chess team (under 16). She
thoroughly enjoys gardening and nature and spends her free time
reading.
Newly Elected Member of IFCC Executive Board Professor Larry J.
Kricka, United States of America

Larry J. Kricka D. Phil., F.A.C.B., C.Sci., C.Chem.,
F.R.S.C., F.R.C.Path., is Professor of Pathology and Laboratory
Medicine at the University of Pennsylvania and Director of the
General Chemistry Laboratory and Director of the Critical Care
Laboratory at the University of Pennsylvania Medical
Center.
Awards and honors include:- the Society of Analytical Chemistry
Silver Medal (Royal Society of Chemistry) (1981), British
Technology Group Academic Enterprise Competition Award (1985),
Prince of Wales Award for Innovation and Production (1989), Queens
Award for Technological Achievement (1990), Rank Prize for
Opto-Electronics (1991), the AACC Award for Outstanding
Contributions to Clinical Chemistry in a Selected Area of Research
(1998), and the Ullman Award (2006). In 2002 Dr Kricka was
the Distinguished Visiting Scholar at Christ's College, Cambridge,
England.
Research interests include analytical applications of
bioluminescence and chemiluminescence, DNA probe assays, analytical
microchips for genetic and other types of testing, analytical
applications of nanotechnology, analytical interferences caused by
heterophile antibodies and direct to consumer testing. Dr
Kricka holds over 30 U.S. patents; and is the author/co-author of
over 500 articles, abstracts, book chapters, and papers; and 22
books. He is Editor-in-chief of Luminescence, a member of the
editorial board of Clinical Chemistry, Lab-on-a-chip, and
Analytical Biochemistry, and past Editor of the Journal of
Immunoassay. He was President of the American Association for
Clinical Chemistry in 2001 and is currently President of the
International Society for Bioluminescence and Chemiluminescence and
will be a member of the International Federation of Clinical
Chemistry and Laboratory Medicine (IFCC) Executive Board beginning
in 2012.
Changes to the Governance:
Under the chairmanship of the President the Council considered
and voted on a number of proposals for changing the governance and
operation of IFCC. Council approved:
1. President Elect:
At the next Council elections in 2014 the post of Vice President
will be discontinued. The President Elect will replace it.
2. Terms of Office for President Elect and Past
President:
With effect from January 2015 the term of office of the Past
President will be reduced from three years to two years. The
President Elect will be elected at a time that enables him/her to
take over from the Past President and serve for the final year of
an Executive Board, before submitting himself/herself for election
as the next President
3. Electronic Voting:
The next Council elections for
the Executive Board that will commence in 2015 will be conducted by
an electronic ballot of Full Members rather than by personal vote
at the Council meeting
The IFCC Rules and Statutes will
require amendment to permit these changes in governance. That will
be a task for the next Executive Board.
Membership Subscription:
The Council noted that the
membership subscription had remained unchanged for 12 years. It
then agreed to an increase in the baseline membership subscription
from 6.0 to 6.5 Swiss Francs per member of the National Society.
This revised membership subscription will apply from 2012 and last
for at least three years. In order to soften the financial
burden a little the Council also agreed to a modest differential
according to the wealth of the country as defined by the World
Bank. Therefore, the membership subscription that will apply
will be:
- 6.5 Swiss Francs per member in High Income countries
- 6.0 Swiss Francs per member in Upper Middle Income
countries
- 5.5 Swiss Francs per member in Lower Middle Income
countries
- 4.0 Swiss Francs per member in Low Income countries
IFCC WorldLab 2017:
The President announced that the Executive Board, on the advice
of the Committee for Congresses and Conferences, had selected
Durban in South Africa as the host city for IFCC WorldLab 2017.